Letter: serum I‐FABP as marker for enterocyte damage in first‐degree relatives of patients with coeliac disease – authors’ reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|1|122-122

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.1, 2015-07, pp. : 122-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: serum I‐FABP as marker for enterocyte damage in first‐degree relatives of patients with coeliac disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 1, 2015-07 ,pp. : 121-122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: lymphocytic gastritis and coeliac disease — authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 938-938

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: metabolic syndrome in patients with coeliac disease on a gluten‐free diet – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 796-796

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response inhibition and interference control in patients with bipolar I disorder and first‐degree relatives

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 17, Iss. 7, 2015-11 ,pp. : 781-794

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 13, 2015-11 ,pp. : 1759-1766

John Wiley & Sons Inc

Access to resources Recommend Favorite